{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:34:43Z","timestamp":1790775283230,"version":"4.1.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Senticol 2 is a randomized multicenter trial in the treatment of early-stage cervical cancer patients. The aim of the Senticol 2 study was to compare the effect of sentinel-lymph-node biopsy (SLNB) to that of SLNB + pelvic lymphadenectomy (PLND), and to determine the postoperative lymphatic morbidity in the two groups. Here, we report a secondary objective of this study: the follow up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and Methods<\/jats:title><jats:p>In the Senticol 2 trial, patients underwent a laparoscopy with a sentinel-node-detection procedure and were randomized into two groups, namely: Group A, in which participants received SLNB, and Group B, in which participants received SLNB + PLND. Patients with an intra-operative macroscopically suspicious lymph node, were given a frozen-section evaluation and were randomized only if the results were negative. All of the patients received follow up with a clinical examination at 1, 3, and 6 months after surgery, and then every 3\u20134 months after that. The median follow up was 51 months (4 years and 3 months).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Disease-free survival after 4 years for the SLNB group and the SLNB + PLND group were 89.51% and 93.1% (<jats:italic>p<\/jats:italic> = 0.53), respectively. The only statistical factor associated with recurrence in the univariate analysis was the adjuvant radiotherapy. No other factors, including the age of the patients, histological type, tumor size, lymph vascular space invasion (LVSI), and positive nodal status, were significant in the univariate or multivariate analyses. The overall survival rates after 4 years in the SLNB and SLNB + PLND groups were 95.2% and 96% (<jats:italic>p<\/jats:italic> = 0.97), with five and four deaths, respectively. The univariate and multivariate analyses did not find any prognostic factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This randomized study confirmed the results of the Senticol 1 study and supports the sentinel lymph node (SLN) technique as a safe technique for use in patients with early-stage cervical cancer treated with SLNB only. Disease-free survival after 4 years was similar in patients treated with SLN biopsy and patients who underwent a lymphadenectomy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2020.621518","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T10:52:35Z","timestamp":1613818355000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial"],"prefix":"10.3389","volume":"10","author":[{"given":"Guillaume","family":"Favre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Guani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Balaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Magaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Lecuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Mathevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S0020-7292(06)60030-1","article-title":"Carcinoma Cervix Uteri","volume":"95","author":"Quinn","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.09.076","article-title":"The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review","volume":"139","author":"Tax","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0432","article-title":"Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study","volume":"29","author":"L\u00e9curu","year":"2011","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ygyno.2017.03.029","article-title":"Sentinel lymph node biopsy for early cervical cancer: Results of a randomized prospective, multicenter study (Senticol 2) comparing adding pelvic lymph node dissection vs sentinel node biopsy only","volume":"145","author":"Mathevet","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B7","unstructured":"Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology6484\n            KohWJ\n            Abu-RustumNR\n            BeanS\n            BradleyK\n            CamposSM\n            ChoKR\n          10.6004\/jnccn.2019.0001J Natl Compr Canc Netw172019"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12969","article-title":"Corrigendum to Revised FIGO staging for carcinoma of the cervix uteri","volume":"147","author":"Bhatla","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1200\/JCO.2020.38.15_suppl.6028","article-title":"Histopathological validation of the sentinel node technique in early-stage cervical cancer patients","volume":"269","author":"Mathevet","year":"2020","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09328-2","article-title":"Histopathological validation of the sentinel node technique in early-stage cervical cancer patients","author":"Mathevet","year":"","journal-title":"Ann Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001710","article-title":"Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer","volume":"30","author":"Santoro","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5387","article-title":"A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol","volume":"73","author":"Sedlis","year":"1999","journal-title":"Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-ESGO.1","article-title":"SUCCOR study. An international european cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009, <4 cm) cervical cancer operated in 2013\u20132014","volume":"29","author":"Chiva","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000332","article-title":"SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study","volume":"29","author":"Lecuru","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2018-000010","article-title":"A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX)","volume":"29","author":"Cibula","year":"2019","journal-title":"Int J Gynecol Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.621518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T10:52:51Z","timestamp":1613818371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.621518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":16,"alternative-id":["10.3389\/fonc.2020.621518"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.621518","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"article-number":"621518"}}